DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Ouaghlidi A, Rehring E, Holst JJ.
The dipeptidyl peptidase 4 inhibitor vildagliptin does not accentuate
glibenclamide-induced hypoglycemia but reduces glucose-induced glucagon-like
peptide 1 and gastric inhibitory polypeptide secretion.
J Clinical Endocrinology & Metabolism 2007;
92: 4165-4171
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.